Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FluTBI Conditioning for Allogeneic HSCT in Older ALL Patients
NCT01991457Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Aug 2013
- Primary completion
- Jan 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of fludarabine in acute lymphoblastic leukemia (ALL), sponsored by University of Alabama at Birmingham. Started Aug 2013; status: completed.
02
Drugs
fludarabine
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT01991457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01991457.